Suppr超能文献

马来西亚新冠肺炎定点医疗机构医护人员中新冠病毒2型抗体的血清学监测。

Serology surveillance of SARS-CoV-2 antibodies among healthcare workers in COVID-19 designated facilities in Malaysia.

作者信息

Woon Yuan Liang, Lee Yee Leng, Chong Yoong Min, Ayub Nor Aliya, Krishnabahawan Swarna Lata, Lau June Fei Wen, Subramaniam-Kalianan Ramani, Sam I-Ching, Chan Yoke Fun, Sevalingam Raj Kumar, Ramli Azura, Chuah Chuan Huan, Mat-Hussin Hani, Leong Chee Loon, Chidambaram Suresh Kumar, Peariasamy Kalaiarasu M, Goh Pik Pin

机构信息

Center for Clinical Epidemiology, Institute for Clinical Research, National Institutes of Health, Ministry of Health, Malaysia.

Clinical Research Center, Sungai Buloh Hospital, Ministry of Health, Malaysia.

出版信息

Lancet Reg Health West Pac. 2021 Apr;9:100123. doi: 10.1016/j.lanwpc.2021.100123. Epub 2021 Mar 21.

Abstract

BACKGROUND

Asymptomatic severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infections are well documented. Healthcare workers (HCW) are at increased risk of infection due to occupational exposure to infected patients. We aim to determine the prevalence of SARS-CoV-2 antibodies among HCW who did not come to medical attention.

METHODS

We prospectively recruited 400 HCW from the National Public Health Laboratory and two COVID-19 designated public hospitals in Klang Valley, Malaysia between 13/4/2020 and 12/5/2020. Quota sampling was used to ensure representativeness of HCW involved in direct and indirect patient care. All participants answered a self-administered questionnaire and blood samples were taken to test for SARS-CoV-2 antibodies by surrogate virus neutralization test.

FINDINGS

The study population comprised 154 (38.5%) nurses, 103 (25.8%) medical doctors, 47 (11.8%) laboratory technologists and others (23.9%). A majority (68.9%) reported exposure to SARS-CoV-2 in the past month within their respective workplaces. Adherence to personal protection equipment (PPE) guidelines and hand hygiene were good, ranging from 91-100% compliance. None (95% CI: 0, 0.0095) of the participants had SARS-CoV-2 antibodies detected, despite 182 (45.5%) reporting some symptoms one month prior to study recruitment. One hundred and fifteen (29%) of participants claimed to have had contact with known COVID-19 persons outside of their workplace.

INTERPRETATION

Zero seroprevalence among HCW suggests a low incidence of undiagnosed COVID-19 infection in our healthcare setting during the first local wave of SARS-CoV-2 infection. The occupational risk of SARS-CoV-2 transmission within healthcare facilities can be prevented by adherence to infection control measures and appropriate use of PPE.

摘要

背景

无症状严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染已有充分记录。医护人员由于职业接触感染患者,感染风险增加。我们旨在确定未就医的医护人员中SARS-CoV-2抗体的流行率。

方法

2020年4月13日至2020年5月12日期间,我们从马来西亚巴生谷的国家公共卫生实验室和两家指定的新冠肺炎公立医院前瞻性招募了400名医护人员。采用配额抽样以确保参与直接和间接患者护理的医护人员具有代表性。所有参与者都回答了一份自行填写的问卷,并采集血样通过替代病毒中和试验检测SARS-CoV-2抗体。

研究结果

研究人群包括154名(38.5%)护士、103名(25.8%)医生、47名(11.8%)实验室技术人员和其他人员(23.9%)。大多数(68.9%)报告在过去一个月内在各自工作场所接触过SARS-CoV-2。对个人防护装备(PPE)指南和手卫生的遵守情况良好,依从率在91%-100%之间。尽管182名(45.5%)参与者在研究招募前一个月报告有一些症状,但没有参与者检测到SARS-CoV-2抗体(95%CI:0,0.0095)。115名(29%)参与者声称在工作场所以外接触过已知的新冠肺炎患者。

解读

医护人员中血清阳性率为零表明在SARS-CoV-2感染的第一波本地疫情期间,我们的医疗机构中未诊断出的新冠肺炎感染发生率较低。通过遵守感染控制措施和正确使用个人防护装备,可以预防医疗机构内SARS-CoV-2传播的职业风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a467/8315377/d19568a85cd3/gr1.jpg

相似文献

1
Serology surveillance of SARS-CoV-2 antibodies among healthcare workers in COVID-19 designated facilities in Malaysia.
Lancet Reg Health West Pac. 2021 Apr;9:100123. doi: 10.1016/j.lanwpc.2021.100123. Epub 2021 Mar 21.
4
Serology suggests adequate safety measures to protect healthcare workers from COVID-19 in Shiga Prefecture, Japan.
PLoS One. 2022 Jun 24;17(6):e0270334. doi: 10.1371/journal.pone.0270334. eCollection 2022.
10
Healthcare Workers' SARS-CoV-2 Infections in Four Hospital Outbreaks during Delta Variant Prevalence in Sydney, Australia.
Nurs Res Pract. 2023 Sep 14;2023:1806909. doi: 10.1155/2023/1806909. eCollection 2023.

引用本文的文献

1
The seroprevalence of SARS-CoV-2 infection in Malaysia: 7 August to 11 October 2020.
Influenza Other Respir Viruses. 2023 Oct 1;17(10):e13193. doi: 10.1111/irv.13193. eCollection 2023 Oct.
2
SARS-CoV-2 Antibody Dynamics in Healthcare Workers after mRNA Vaccination.
Vaccines (Basel). 2023 Feb 4;11(2):358. doi: 10.3390/vaccines11020358.
3
Occupational Disease and Injury in Malaysia: A Thematic Review of Literature from 2016 to 2021.
J Environ Public Health. 2023 Jan 31;2023:1798434. doi: 10.1155/2023/1798434. eCollection 2023.
4
Twice evasions of Omicron variants explain the temporal patterns in six Asian and Oceanic countries.
BMC Infect Dis. 2023 Jan 13;23(1):25. doi: 10.1186/s12879-023-07984-9.
6
COVID-19 infection among health care workers: A hospital based study from Indian state of Meghalaya.
J Family Med Prim Care. 2022 May;11(5):1898-1901. doi: 10.4103/jfmpc.jfmpc_1733_21. Epub 2022 May 14.
7
Are hospitals epicentres of COVID19 transmission? Findings of serial serosurveys among healthcare workers from a tertiary hospital in South India.
Indian J Med Microbiol. 2022 Jan-Mar;40(1):141-143. doi: 10.1016/j.ijmmb.2021.10.006. Epub 2021 Nov 10.
9
COVID-19 Prevention and Control Measures in Workplace Settings: A Rapid Review and Meta-Analysis.
Int J Environ Res Public Health. 2021 Jul 24;18(15):7847. doi: 10.3390/ijerph18157847.
10
Seroprevalence of SARS-CoV-2 specific IgG antibodies among eye care workers in South India.
Indian J Med Microbiol. 2021 Oct-Dec;39(4):467-472. doi: 10.1016/j.ijmmb.2021.06.014. Epub 2021 Jul 10.

本文引用的文献

1
Clinical characteristics and risk factors for severe COVID-19 infections in Malaysia: A nationwide observational study.
Lancet Reg Health West Pac. 2020 Nov;4:100055. doi: 10.1016/j.lanwpc.2020.100055. Epub 2020 Nov 17.
2
SARS-CoV-2 neutralizing antibody levels are correlated with severity of COVID-19 pneumonia.
Biomed Pharmacother. 2020 Oct;130:110629. doi: 10.1016/j.biopha.2020.110629. Epub 2020 Aug 13.
4
Seroprevalence of SARS-CoV-2 (COVID-19) among healthcare workers in Saudi Arabia: comparing case and control hospitals.
Diagn Microbiol Infect Dis. 2021 Mar;99(3):115273. doi: 10.1016/j.diagmicrobio.2020.115273. Epub 2020 Nov 20.
5
Seroprevalence of SARS-CoV-2 antibodies and associated factors in healthcare workers: a systematic review and meta-analysis.
J Hosp Infect. 2021 Feb;108:120-134. doi: 10.1016/j.jhin.2020.11.008. Epub 2020 Nov 16.
7
SARS-CoV-2 seroprevalence and transmission risk factors among high-risk close contacts: a retrospective cohort study.
Lancet Infect Dis. 2021 Mar;21(3):333-343. doi: 10.1016/S1473-3099(20)30833-1. Epub 2020 Nov 2.
8
Head-to-head evaluation on diagnostic accuracies of six SARS-CoV-2 serological assays.
Pathology. 2020 Dec;52(7):770-777. doi: 10.1016/j.pathol.2020.09.007. Epub 2020 Sep 30.
9
Validation and clinical evaluation of a SARS-CoV-2 surrogate virus neutralisation test (sVNT).
Emerg Microbes Infect. 2020 Dec;9(1):2394-2403. doi: 10.1080/22221751.2020.1835448.
10
Analysis of SARS-CoV-2 Transmission in Different Settings, Brunei.
Emerg Infect Dis. 2020 Nov;26(11):2598-2606. doi: 10.3201/eid2611.202263. Epub 2020 Oct 9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验